BR9606890A - Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes - Google Patents

Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes

Info

Publication number
BR9606890A
BR9606890A BR9606890A BR9606890A BR9606890A BR 9606890 A BR9606890 A BR 9606890A BR 9606890 A BR9606890 A BR 9606890A BR 9606890 A BR9606890 A BR 9606890A BR 9606890 A BR9606890 A BR 9606890A
Authority
BR
Brazil
Prior art keywords
treatment
prophylaxis
hyperlipoproteinemia
hypertriglyceridemia
hypercholesterolemia
Prior art date
Application number
BR9606890A
Other languages
English (en)
Inventor
Michael Shalmi
Niels Korsgaard
Steven Bain
Birgitte Hjort Guldhammer
Jan Ulrik Weis
Charles E Hart
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9606890A publication Critical patent/BR9606890A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
BR9606890A 1995-01-13 1996-01-10 Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes BR9606890A (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK4395 1995-01-13
DK4195 1995-01-13
DK6995 1995-01-20
DK77795 1995-06-30
DK76695 1995-06-30
DK76795 1995-06-30
PCT/DK1996/000014 WO1996021443A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment

Publications (1)

Publication Number Publication Date
BR9606890A true BR9606890A (pt) 1997-10-28

Family

ID=27545138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606890A BR9606890A (pt) 1995-01-13 1996-01-10 Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes

Country Status (11)

Country Link
EP (1) EP0804189A1 (pt)
JP (1) JPH10511961A (pt)
CN (1) CN1168098A (pt)
AU (1) AU4329296A (pt)
BR (1) BR9606890A (pt)
CA (1) CA2208859A1 (pt)
CZ (1) CZ212397A3 (pt)
HU (1) HUP9800521A3 (pt)
IL (1) IL116745A (pt)
NO (1) NO973241L (pt)
WO (1) WO1996021443A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis
WO1999048497A1 (en) * 1998-03-20 1999-09-30 Novo Nordisk A/S USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US7601855B2 (en) 2004-09-21 2009-10-13 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
KR102395543B1 (ko) 2014-02-07 2022-05-09 카지아 테라퓨틱스 리미티드 기능화된 벤조피란 화합물 및 이의 용도
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
CN1168098A (zh) 1997-12-17
CZ212397A3 (en) 1997-11-12
IL116745A (en) 1999-12-22
HUP9800521A2 (hu) 1998-12-28
IL116745A0 (en) 1996-05-14
WO1996021443A1 (en) 1996-07-18
MX9705214A (es) 1997-10-31
NO973241D0 (no) 1997-07-11
JPH10511961A (ja) 1998-11-17
CA2208859A1 (en) 1996-07-18
EP0804189A1 (en) 1997-11-05
NO973241L (no) 1997-07-11
AU4329296A (en) 1996-07-31
HUP9800521A3 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
BR9504072A (pt) Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit
BR9306619A (pt) Glicosídeos esteroidais para o tratamento da hipercolesterolemia
BR9610248A (pt) Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto
NO974541D0 (no) Engangs-bleiebukse
DE69411053D1 (de) Wegwerfwindeln
DE69408640T2 (de) Wegwerfwindel
DE69618170T2 (de) Wegwerfwindel
DE69619799D1 (de) Wegwerfwindel
KR970005253A (ko) 일회용 기저귀
BR9604632A (pt) Compostos bicíclicos aromáticos utilizaçao de pelo menos um dos compostos composiçao farmacêutica composiçao cosmética e utilizaçao de uma composiçao cosmética
DE69617646T2 (de) Wegwerfwindel
AU9020591A (en) Method of treatment of waste paper or the like
DE69433144D1 (de) Wegwerfwindel
PT93791A (pt) Dispositivo para tratamento de residuos medicos especiais
BR9606890A (pt) Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes
BR9611228A (pt) Tudo resistente ao fogo
NO952820D0 (no) Behandling av avfallspetroleum
KR950704653A (ko) 독성 폐기물의 처리(treatment of toxic wastes)
BR9611234A (pt) Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos
BR9407998A (pt) Instalaçao para o tratamento de matérias biológicas hidratadas
BR9510554A (pt) Uso de moléculas de ligação de mch-ii e/ou moléculas de imitação para a prevenção e/ou tratamento de doenças inflamatórias
FI942908A0 (fi) Uusia BHT-eetteriyhdisteitä ja niiden käyttö hyperlipidemian ja ateroskleroosin vastaisina lääkkeinä
BR9611838A (pt) Compostos úteis para a enibição de replicação de HIV-1 E mutantes de HIV-1
FI964113A (fi) Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö
DE59607760D1 (de) Kosmetische und/oder pharmazeutische Emulsionen

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal